Co-Authors
This is a "connection" page, showing publications co-authored by Nigel Mackman and Ton Lisman.
Connection Strength
1.338
-
Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report". Arterioscler Thromb Vasc Biol. 2021 06; 41(6):e381-e382.
Score: 0.237
-
COVID-19 is Associated with an Acquired Factor XIII Deficiency. Thromb Haemost. 2021 12; 121(12):1668-1669.
Score: 0.234
-
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. 2021 02 09; 5(3):756-759.
Score: 0.232
-
Elevated factor V activity and antigen levels in patients with Covid-19 are related to disease severity and 30-day mortality. Am J Hematol. 2021 04 01; 96(4):E98-E100.
Score: 0.231
-
Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality. Res Pract Thromb Haemost. 2021 Jan; 5(1):132-141.
Score: 0.229
-
Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers. J Med Virol. 2021 10; 93(10):5908-5916.
Score: 0.060
-
Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report. Arterioscler Thromb Vasc Biol. 2021 02; 41(2):878-882.
Score: 0.057
-
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19. Arterioscler Thromb Vasc Biol. 2021 02; 41(2):988-994.
Score: 0.057